Diabetic retinopathy appears to be more common in young people than earlier thought, leaving more of them at risk for eye ...

The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...

Mazdutide – a once-weekly injectable Innovent licensed from Lilly – was submitted to China's National Medical Products Administration ... agonists include Boehringer Ingelheim and Zealand ...

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, hosted a dedicated event aimed at improving outcomes for patients living with cardiovascular, renal, and metabolic (CRM) ...

Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...

“Additionally, consumers will also get to take advantage of RHEA Generics’ wide availability at 1,200 Mercury Drug outlets ...

The global GLP-1 receptor agonist market is poised for extraordinary expansion, driven by an increase in therapeutic applications and favorable market projections. Recent analysis indicates a ...

Germany, Norway, Luxembourg, Denmark, and Ireland made the biggest new commitments to WHO funding.View on euronews ...

Oct. 9, 2024 — A new study shows that people with type 2 diabetes have lower levels of the protein that breaks down and converts creatine in the muscles. This leads to impaired function of the ...

β-cell–Centric Construct: A Potential Model for the Classification of DM Given the above discussion, the issue is not "what is LADA" or any clinical presentation of DM under the current system.

Border Free Health, a trusted diabetic supplier, offers a wide range of products and services tailored to meet the needs of those living with this chronic condition. A Wide Range of Diabetes ...